Related references
Note: Only part of the references are listed.IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
Jia Dai et al.
PLOS ONE (2013)
Disruption of mindin exacerbates cardiac hypertrophy and fibrosis
Zhou-Yan Bian et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Molecular mechanisms in evolutionary cardiology failure
Bernard Swynghedauw et al.
ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE (2010)
Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
Izhak Kehat et al.
ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE (2010)
Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling
Di-Fei Shen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
TRAF5 Deficiency Accelerates Atherogenesis in Mice by Increasing Inflammatory Cell Recruitment and Foam Cell Formation
Anna Missiou et al.
CIRCULATION RESEARCH (2010)
LIM and Cysteine-Rich Domains 1 Regulates Cardiac Hypertrophy by Targeting Calcineurin/Nuclear Factor of Activated T Cells Signaling
Zhou-Yan Bian et al.
HYPERTENSION (2010)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
TRAF5 Is a Downstream Target of MAVS in Antiviral Innate Immune Signaling
Eric D. Tang et al.
PLOS ONE (2010)
Molecular targets and regulators of cardiac hypertrophy
Rohini Agrawal et al.
PHARMACOLOGICAL RESEARCH (2010)
Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload
Hongliang Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
NF-kappa B activation is required for adaptive cardiac hypertrophy
Laura Zelarayan et al.
CARDIOVASCULAR RESEARCH (2009)
Tumor Suppressor Ras-Association Domain Family 1 Isoform A Is a Novel Regulator of Cardiac Hypertrophy
Delvac Oceandy et al.
CIRCULATION (2009)
Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis
Zhouyan Bian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
Jun Cai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3β signaling
Qizhu Tang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40
Zachary J. Kraus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
αB-Crystallin Suppresses Pressure Overload Cardiac Hypertrophy
Asangi R. K. Kumarapeli et al.
CIRCULATION RESEARCH (2008)
Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model
Alexander Schuh et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice
Hong-Liang Li et al.
HYPERTENSION (2007)
Cardiac hypertrophy: Mechanisms and therapeutic opportunities
Sudhiranjan Gupta et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
TGFβ, cardiac fibroblasts, and the fibrotic response
Andrew Leask
CARDIOVASCULAR RESEARCH (2007)
The fuzzy logic of physiological cardiac hypertrophy
Gerald W. Dorn
HYPERTENSION (2007)
Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction
Hong-Liang Li et al.
CIRCULATION (2007)
ECM remodeling in hypertensive heart disease
Bradford C. Berk et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
被撤回的出版物: Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling (Retracted article. See vol. 53, pg. 742, 2012)
Samarjit Das et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Differential gene expression in infarct sear and viable myocardium from rat heart following coronary ligation
YJ Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2004)
NF-κB activation is required for the development of cardiac hypertrophy in vivo
YH Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death
K Tada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activation of TRAF5 and TRAF6 signal cascades negatively regulates the latent replication origin of Epstein-Barr virus through p38 mitogen-activated protein kinase
M Shirakata et al.
JOURNAL OF VIROLOGY (2001)
The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway
L Sanz et al.
EMBO JOURNAL (2000)
Share Paper
